China built resilience to an energy shock — it’s paid off for Chinese assets amid the Iran war
Chinese assets emerged as an unlikely bastion of stability during a period where other traditional havens, such as gold and U.S. Treasurys, stumbled.
Why ships bound for the Middle East are piling up across Asia
Congestion in Singapore’s waters is rising as the Iran war disrupts shipping routes, forcing vessels bound for the Middle East to drop anchor near its ports.
Ireland gridlocked by fuel protests as Iran war drives prices higher
Protestors are taking issue with the government’s response to the spike in fuel prices since the onset of the Iran war.
Stefano Gabbana has stepped down as Dolce & Gabbana chairman but will keep a creative role
Stefano Gabbana has stepped down as chairman of the Italian fashion house that he co-founded with Domenico Dolce, but will continue in his creative role.
The Tech Download: Reputational damage, supply chain issues and local investment. What’s next for Middle East tech?
A two-week ceasefire was agreed between the U.S. and Iran on Wednesday, prompting hopes of the beginnings of the end of the conflict.
Alibaba just revealed it’s behind a viral AI video model dominating leaderboards
A mysterious AI video model that has ascended global leaderboards has been confirmed as a project under Alibaba.
China’s Xi invokes ‘threat’ of Taiwan independence in first cross-strait opposition talks in a decade
Xi Jinping hosted Taiwan’s main opposition leader in Beijing for the first time in a decade, ahead of a high-stakes meeting with Trump in May and Taiwan’s presidential election in 2028.
TSMC posts 35% jump in revenue to new record high as AI chip demand stays strong
TSMC is benefiting from sustained demand for advanced semiconductors from its key customers like Apple and Nvidia.
Behind China’s ‘active efforts’ for an Iran ceasefire: Business trumps politics
The big risk for Beijing is that the Iran war drags down global demand for the exports that are driving China’s economic growth.
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
